Brett Cunningham, MD
Psychiatry · Spencer, OKNPI 1730315193
Payments from drug & device makers
Across 71 payments — averaging $18.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$311
- Johnson & Johnson$234
- AbbVie$187
- Otsuka America Pharmaceutical, Inc.$164
- Indivior Inc.$125
- Vanda Pharmaceuticals Inc.$81
- plus $189 from 5 others
What the payments were for
- Food & beverage$1,292100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 13 | $311 |
| Johnson & Johnson | 15 | $234 |
| AbbVie | 10 | $187 |
| Otsuka America Pharmaceutical, Inc. | 9 | $164 |
| Indivior Inc. | 8 | $125 |
| Vanda Pharmaceuticals Inc. | 5 | $81 |
| Teva Pharmaceuticals USA, Inc. | 5 | $81 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $44 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Lundbeck LLC | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
How this compares
$1,292 in reported general payments places this provider in the 75th percentile of 328 psychiatry providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 23 | $3,897 |
| Duloxetine Hcl | 26 | $352 |
| Fluoxetine Hcl | 11 | $309 |
| Quetiapine Fumarate | 27 | $285 |
| Propranolol Hcl | 18 | $200 |
| Doxepin Hcl | 12 | $172 |
| Amitriptyline Hcl | 30 | $165 |
| Mirtazapine | 26 | $150 |
| Trazodone Hcl | 24 | $79 |
| Sertraline Hcl | 14 | $48 |
| Lamotrigine | 13 | $24 |
| Metformin Hcl | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Spencer
- Louise ThurmanOklahoma City$6.2M
- Veronique SebastianOklahoma City$3.8M
- Marvin PeytonOklahoma City$3.2M
- Sarah LandTulsa$2.8M
- Robert MortonAda$1.9M
- Willis HollowayOklahoma City$1.4M
- Courtney NixonOklahoma City$1.2M
- Surinder RandhawaOklahoma City$142K
- Adonis Al BotrosOklahoma City$73K
- Ondria GleasonTulsa$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.